No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 4.1x · 10Y median 4.6x · 27th percentile · as of Sep 9, 2026
Annualized revenue (TTM) · by quarter, last 15
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-09-21T18:26:06.371Z. Latest historical point 2026-09-09. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Veralto Corporation (VLTO) stock was $95.00 as of Sep 21, 2026, 2:24 PM EDT, up 0.54% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -9.3%
Veralto Corporation is a global provider specializing in critical solutions across water quality management, brand protection, and packaging aesthetics. Its operations are structured into two primary divisions: Water Quality (WQ) and Product Quality & Innovation (PQI).
Industrial - Pollution & Treatment Controls · Waltham, MA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Oct 27, 2026
36 days away
EPS Estimate
1.09
Revenue Est.
$1.50B
Last Quarter Results
EPS
$1.11
vs Estimate
$1.01
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1VLTO | $23.16B | $95.00 | +0.54% | -9.35% | N/A | N/A | N/A |
| 2HUBB | $24.05B | $455.12 | +1.83% | +3.35% | +20.92% | +18.43% | vs VLTO |
| 3JBHT | $21.98B | $234.06 | -0.08% | +92.83% | +10.25% | +14.29% | vs VLTO |
| 4MTUAY | $21.72B | $201.55 | +3.08% | -5.20% | +13.42% | +15.79% | vs VLTO |
| 5DOV | $25.18B | $186.97 | -0.24% | +7.25% | +2.98% | +14.80% | vs VLTO |
| 6XYL | $25.18B | $107.86 | +0.28% | -20.66% | -3.08% | +9.60% | vs VLTO |
TTM
4.07
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$1.47B
vs Estimate
$1.45B
Consensus Rating
Based on 14 analysts
Average Price Target
$114.00
+20.0% upside
Low
$100.00
Current
$95.00
High
$136.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $1.08 | $1.09 | $1.10 | 7 |
| Quarter ending Jan 2027 | $1.12 | $1.13 | $1.14 | 6 |
| Quarter ending Apr 2027 | $1.14 | $1.15 | $1.16 | 2 |
| Quarter ending Jul 2027 | $1.13 | $1.14 | $1.15 | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $4.31 | $4.38 | $4.41 | 7 |
| FY 2027 | $4.71 | $4.78 | $4.82 | 7 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Oct 2026 | $1.49B | $1.50B | $1.51B | 6 |
| Quarter ending Jan 2027 | $1.51B | $1.52B | $1.53B | 6 |
| Quarter ending Apr 2027 | $1.50B | $1.51B | $1.52B | 3 |
| Quarter ending Jul 2027 | $1.54B | $1.55B | $1.56B | 3 |
Annual
| Period | Low |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $5.84B | $5.91B | $5.92B | 9 |
| FY 2027 | $6.06B | $6.23B | $6.33B | 9 |
